{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:01:30Z","timestamp":1791277290196,"version":"4.1.0"},"reference-count":32,"publisher":"Scientific Scholar","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"\n Background & objectives:<\/jats:title>\n Antibiotic administration within one hour of presentation is a standard of care goal in the treatment of febrile neutropenia (FN). The objective of this study was to find the proportion of children with FN who had a time to antibiotic administration (TTA) of \u226460 min and evaluate causes for delay.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n A prospective analysis of children presenting with FN was carried out. The primary outcome was the proportion of patients who received antibiotics within one hour of triage. Predictor variables included the place of presentation, time and day of the week. A root cause analysis was done for delayed TTA.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n A total of 211 children (mean age: 6 yr) with FN were evaluated for TTA. The primary outcome of TTA, (\u226460 min) was achieved in 66 per cent children. The odds of delayed TTA were lower when patients were evaluated in the night. Odds of delayed TTA were higher in patients who had no focus of infection, when assessed in the oncology daycare and when assessed over the weekend, but none were statistically significant. Waiting for blood results (30%), delay in preparing antibiotics (21%) and delay in allotting bed (30%) were significant causes for delay.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n Two-thirds of the patients achieved the target TTA of \u226460 min. Patients seen during the daytime and on weekends had a delay in TTA compared to those presenting at the evening or night or weekdays. Children with a focus for fever received antibiotics earlier. Logistics for admission and awaiting blood counts were chief causes for delay.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_2483_19","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T05:26:05Z","timestamp":1647494765000},"page":"615-622","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Time to antibiotic administration in children with febrile neutropenia: Report from a low middle-income country"],"prefix":"10.25259","volume":"154","author":[{"given":"Namrata","family":"Todurkar","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Advanced Pediatric Centre, Pediatric Hematology Oncology Unit, Postgraduate Institute of Medical Education & Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Trehan","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Advanced Pediatric Centre, Pediatric Hematology Oncology Unit, Postgraduate Institute of Medical Education & Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Bansal","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Advanced Pediatric Centre, Pediatric Hematology Oncology Unit, Postgraduate Institute of Medical Education & Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"B1-20241212","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients:2017 update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"key":"B2-20241212","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1007\/s00520-017-3776-7","article-title":"Can complications in febrile neutropenia be predicted?Report from a developing country","volume":"25","author":"Oberoi","year":"2017","journal-title":"Support Care Cancer"},{"key":"B3-20241212","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/pbc.25435","article-title":"Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs","volume":"62","author":"Salstrom","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B4-20241212","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer:2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B5-20241212","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1086\/342064","article-title":"Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia","volume":"35","author":"Santolaya","year":"2002","journal-title":"Clin Infect Dis"},{"key":"B6-20241212","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/PEC.0000000000000077","article-title":"Standardized process used in the emergency department for pediatric oncology patients with fever and neutropenia improves time to the first dose of antibiotics","volume":"30","author":"Cash","year":"2014","journal-title":"Pediatr Emerg Care"},{"key":"B7-20241212","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1128\/AAC.01553-07","article-title":"Delay of active antimicrobial therapy and mortality among patients with bacteremia:Impact of severe neutropenia","volume":"52","author":"Lin","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"B9-20241212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropaenia:ESMO clinical practice guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann Oncol"},{"key":"B10-20241212","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1200\/JCO.2009.27.0421","article-title":"Outcomes for children and adolescents with cancer:challenges for the twenty-first century","volume":"28","author":"Smith","year":"2010","journal-title":"J Clin Oncol"},{"key":"B11-20241212","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3747\/co.v18i6.841","article-title":"Assessment and management of febrile neutropenia in emergency departments within a regional health authority \u2013A benchmark analysis","volume":"18","author":"Szwajcer","year":"2011","journal-title":"Curr Oncol"},{"key":"B12-20241212","first-page":"429","article-title":"CBC testing before physician assessment delays antibiotics in emergency febrile neutropenia patients","volume":"22","author":"Ben-Yakov","year":"2010","journal-title":"Emergencias"},{"key":"B13-20241212","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/1043454208319971","article-title":"Antibiotics in 30 minutes or less for febrile neutropenic patients:A quality control measure in a new hospital","volume":"25","author":"Corey","year":"2008","journal-title":"J Pediatr Oncol Nurs"},{"key":"B14-20241212","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2354.2011.01264.x","article-title":"How prompt is prompt in daily practice?Earlier initiation of empirical antibacterial therapy for the febrile neutropenic patient","volume":"20","author":"van","year":"2011","journal-title":"Eur J Cancer Care (Engl)"},{"key":"B15-20241212","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1188\/04.ONF.711-715","article-title":"Emergency department waiting times for patients with cancer with febrile neutropenia:A pilot study","volume":"31","author":"Nirenberg","year":"2004","journal-title":"Oncol Nurs Forum"},{"key":"B16-20241212","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1188\/02.CJON.337-340","article-title":"Neutropenic fever:One institution's quality improvement project to decrease time from patient arrival to initiation of antibiotic therapy","volume":"6","author":"Baltic","year":"2002","journal-title":"Clin J Oncol Nurs"},{"key":"B17-20241212","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/pbc.23148","article-title":"Time-to-antibiotic administration as a quality of care measure in children with febrile neutropenia:A survey of pediatric oncology centers","volume":"58","author":"McCavit","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"B18-20241212","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/pbc.23418","article-title":"Identification of educational and infrastructural barriers to prompt antibiotic delivery in febrile neutropenia:A quality improvement initiative","volume":"59","author":"Burry","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"B19-20241212","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/PEC.0000000000000362","article-title":"Protocol for reducing time to antibiotics in pediatric patients presenting to an emergency department with fever and neutropenia:Efficacy and barriers","volume":"32","author":"Cohen","year":"2016","journal-title":"Pediatr Emerg Care"},{"key":"B20-20241212","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/bmjqs-2015-004451","article-title":"Sustained reductions in time to antibiotic delivery in febrile immunocompromised children:Results of a quality improvement collaborative","volume":"25","author":"Dandoy","year":"2016","journal-title":"BMJ Qual Saf"},{"key":"B21-20241212","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1442-200X.2011.03363.x","article-title":"Clinical practice guidelines for children with cancer presenting with fever to the emergency room","volume":"53","author":"Pakakasama","year":"2011","journal-title":"Pediatr Int"},{"key":"B22-20241212","doi-asserted-by":"crossref","first-page":"103.e9","DOI":"10.1016\/j.jcrc.2010.05.034","article-title":"Effect of a quality improvement intervention to decrease delays in antibiotic delivery in pediatric febrile neutropenia:A pilot study","volume":"26","author":"Amado","year":"2011","journal-title":"J Crit Care"},{"key":"B23-20241212","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1542\/peds.2012-0153","article-title":"Improving timeliness of antibiotic delivery for patients with fever and suspected neutropenia in a pediatric emergency department","volume":"130","author":"Volpe","year":"2012","journal-title":"Pediatrics"},{"key":"B24-20241212","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/pbc.24485","article-title":"Prompt administration of antibiotics is associated with improved outcomes in febrile neutropenia in children with cancer","volume":"60","author":"Fletcher","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"B25-20241212","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1472-6963-14-162","article-title":"Time to antibiotics and outcomes in cancer patients with febrile neutropenia","volume":"14","author":"Perron","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"B26-20241212","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1128\/AAC.02561-14","article-title":"Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia","volume":"58","author":"Rosa","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"B27-20241212","doi-asserted-by":"crossref","first-page":"e0229828","DOI":"10.1371\/journal.pone.0229828","article-title":"Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department","volume":"15","author":"Peyrony","year":"2020","journal-title":"PLoS One"},{"key":"B28-20241212","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1200\/JOP.2014.002733","article-title":"Reducing time to antibiotic administration for febrile neutropenia in the emergency department","volume":"11","author":"Keng","year":"2015","journal-title":"J Oncol Pract"},{"key":"B29-20241212","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/INF.0b013e3181c3f6f0","article-title":"Risk prediction in pediatric cancer patients with fever and neutropenia","volume":"29","author":"Hakim","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"B30-20241212","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13643-019-1006-8","article-title":"Protocol for a systematic review of time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN) and interventions aiming to reduce TTA","volume":"8","author":"Koenig","year":"2019","journal-title":"Syst Rev"},{"key":"B31-20241212","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1179\/1607845414Y.0000000169","article-title":"Febrile neutropenia:Median door-to-needle time \u2013Results of an initial audit","volume":"20","author":"Ali","year":"2015","journal-title":"Hematology"},{"key":"B32-20241212","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s00520-019-05056-w","article-title":"Interventions aiming to reduce time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN), a systematic review","volume":"28","author":"Koenig","year":"2020","journal-title":"Support Care Cancer"},{"key":"B33-20241212","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1097\/pq9.0000000000000236","article-title":"Optimizing time to antibiotic administration in children with possible febrile neutropenia through quality improvement methodologies","volume":"4","author":"Burns","year":"2019","journal-title":"Pediatr Qual Saf"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.IJMR_2483_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:04:28Z","timestamp":1751497468000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/time-to-antibiotic-administration-in-children-with-febrile-neutropenia-report-from-a-low-middle-income-country\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_2483_19","relation":{},"ISSN":["0971-5916","0975-9174"],"issn-type":[{"value":"0971-5916","type":"print"},{"value":"0975-9174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"2019-11-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}